Insider Transactions in Q2 2020 at Cvs Health Corp (CVS)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Open market or private sale
|
Direct |
270
-5.61%
|
$17,550
$65.0 P/Share
|
|
May 26
2020
|
Jonathan E. Mayhew EVP - Transformation |
SELL
Open market or private sale
|
Direct |
10,556
-69.05%
|
$686,140
$65.0 P/Share
|
|
May 14
2020
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,865
+7.86%
|
$115,630
$62.31 P/Share
|
|
May 14
2020
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,986
+1.67%
|
$123,132
$62.31 P/Share
|
|
May 14
2020
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,955
+9.44%
|
$121,210
$62.31 P/Share
|
|
May 14
2020
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,694
+3.32%
|
$291,028
$62.31 P/Share
|
|
May 14
2020
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,865
+50.0%
|
$115,630
$62.31 P/Share
|
|
May 14
2020
|
Mary L Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,487
+36.25%
|
$154,194
$62.31 P/Share
|
|
May 14
2020
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,955
+5.56%
|
$121,210
$62.31 P/Share
|
|
May 11
2020
|
Alan Lotvin EVP&President-PharmacyServices |
BUY
Open market or private purchase
|
Direct |
5,000
+24.8%
|
$315,000
$63.13 P/Share
|
|
Apr 28
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Open market or private sale
|
Direct |
6,234
-56.41%
|
$405,210
$65.0 P/Share
|
|
Apr 03
2020
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,803
-1.84%
|
$539,165
$55.72 P/Share
|
|
Apr 03
2020
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,017
-1.42%
|
$55,935
$55.72 P/Share
|
|
Apr 03
2020
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,598
-3.32%
|
$87,890
$55.72 P/Share
|
|
Apr 03
2020
|
Thomas M Moriarty EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,944
-5.53%
|
$216,920
$55.72 P/Share
|
|
Apr 03
2020
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,179
-2.03%
|
$119,845
$55.72 P/Share
|
|
Apr 01
2020
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
8,868
-1.71%
|
$514,344
$58.34 P/Share
|
|
Apr 01
2020
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,774
-1.26%
|
$102,892
$58.34 P/Share
|
|
Apr 01
2020
|
Thomas M Moriarty EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-2.77%
|
$104,748
$58.34 P/Share
|
|
Apr 01
2020
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,552
-1.49%
|
$90,016
$58.34 P/Share
|
|
Apr 01
2020
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,109
-2.42%
|
$64,322
$58.34 P/Share
|
|
Apr 01
2020
|
Alan Lotvin EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct |
1,481
-12.72%
|
$85,898
$58.34 P/Share
|
|
Apr 01
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-3.75%
|
$56,434
$58.34 P/Share
|
|
Apr 01
2020
|
Jonathan E. Mayhew EVP - Transformation |
SELL
Payment of exercise price or tax liability
|
Direct |
763
-4.75%
|
$44,254
$58.34 P/Share
|
|
Apr 01
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,713
+27.63%
|
$447,354
$58.34 P/Share
|
|
Apr 01
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-5.67%
|
$39,498
$58.34 P/Share
|